The lung cancer PCR panel market size is projected to be worth US$ 513.9 million in 2023. The market is likely to surpass US$ 1.1 billion by 2033 at a CAGR of 8.0% during the forecast period. Growing lung cancer incidences is aiding the market growth. Lung cancer targeted medicines and precision medicine are greatly aided by PCR panels. These panels assist in identifying patients who may benefit from targeted medicines or immunotherapies by identifying particular genetic abnormalities, including as mutations in genes like EGFR, ALK, ROS1, and others. The need for molecular diagnostics like PCR panels has been fueled by the creation and accessibility of innovative targeted medicines.
Other Drivers Propelling the Demand for Lung Cancer PCR Panel Market include:
Challenges for Companies /Manufacturers in the Lung Cancer PCR Panel Market:
Opportunities in the Lung Cancer PCR Panel Market Industry:
Latest Trends in the Lung Cancer PCR Panel Market:
| Attributes | Details |
|---|---|
| Lung Cancer PCR Panel Market Size (2023) | US$ 513.9 million |
| Lung Cancer PCR Panel Market Projected Size (2033) | US$ 1.1 billion |
| Value CAGR (2023 to 2033) | 8.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2015 to 2022, the global lung cancer PCR panel market experienced a CAGR of 6.7%, reaching a market size of US$ 513.9 million in 2023.
From 2015 to 2022, the global lung cancer PCR panel market industry witnessed steady growth due to the increased prevalence of lung cancer. Lung cancer is one of the top causes of cancer mortality globally. Because of the increased incidence and prevalence of lung cancer, there is a greater need for precise and fast diagnostic methods such as PCR panels.
The creation of PCR panels has been facilitated by advances in genomic research and understanding of the genetic underpinnings of lung cancer. These panels enable the detection of particular gene mutations or modifications linked to lung cancer, allowing for more tailored therapy regimens.
Future Forecast for Lung Cancer PCR Panel Market Industry:
Looking ahead, the global lung cancer PCR panel market industry is expected to rise at a CAGR of 6.7% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 1.1 billion by 2033.
The lung cancer PCR panel market industry is expected to continue its growth trajectory from 2023 to 2033. Precision oncology seeks to give targeted medicines based on an individual's tumor's genetic composition. The need for PCR panels for precise molecular profiling and detection of targetable genetic abnormalities is projected to rise as precision oncology gains importance.
Early identification and diagnosis of lung cancer improves patient outcomes significantly. PCR panels offer the ability to detect genetic changes in early-stage lung cancer, allowing for earlier intervention and better survival rates. The emphasis on early diagnosis is anticipated to drive future demand for PCR panels.
| Country | The United States |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 223.2 million |
| CAGR % 2023 to End of Forecast (2033) | 3.7% |
The lung cancer PCR panel market industry in the United States is expected to reach a market size of US$ 223.2 million by 2033, expanding at a CAGR of 3.7%. Due to the increasing incidence of lung cancer nationwide the market is on the rise. Lung cancer affects a large number of people in the United States. Because of the high frequency of lung cancer, there is a significant market for PCR panels as a diagnostic tool to help in early identification, therapy selection, and disease monitoring. Furthermore, the availability of sophisticated molecular diagnostic technologies, such as PCR panels, boosts the growth of the country's lung cancer PCR panel market.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 29.2 million |
| CAGR % 2023 to End of Forecast (2033) | 3.8% |
The lung cancer PCR panel market industry in the United Kingdom is expected to reach a market share of US$ 29.2 million, expanding at a CAGR of 3.8% during the forecast period. The public's knowledge of lung cancer and the need of early diagnosis has grown in the United Kingdom. Screening programs and early detection measures aid in the growth of the lung cancer PCR panel market in the United Kingdom. The UK has a strong research infrastructure and collaborative efforts between academia, research institutions, and the industry. These collaborations foster the development of advanced diagnostic technologies, including PCR panels, for lung cancer, driving market growth.
| Country | China |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 36.5 million |
| CAGR % 2023 to End of Forecast (2033) | 6.4% |
The lung cancer PCR panel market industry in China is anticipated to reach a market size of US$ 36.5 million, moving at a CAGR of 6.4% during the forecast period. The lung cancer PCR panel market industry in China is expected to grow prominently due to the increasing government initiatives and investments. The Chinese government has prioritized healthcare development and has invested in innovative diagnostic technology. Policies that encourage research and cooperation between academia and business all contribute to the growth of the lung cancer PCR panel market in China. Furthermore, the rising prevalence of lung cancer is driving demand for PCR panels as a diagnostic tool in China.
| Country | Japan |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 48.7 million |
| CAGR % 2023 to End of Forecast (2033) | 6.2% |
The lung cancer PCR panel market industry in Japan is estimated to reach a market size of US$ 48.7 million by 2033, thriving at a CAGR of 6.2%. The market in Japan is predicted to grow because of its advanced healthcare infrastructure. Japan has a sophisticated medical technology and a well-developed healthcare system. The availability of improved diagnostic facilities, as well as a strong emphasis on early diagnosis and personalized medication, all contribute to the expansion of the lung cancer PCR panel market.
| Country | South Korea |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 6.5 million |
| CAGR % 2023 to End of Forecast (2033) | 6.0% |
The lung cancer PCR panel market industry in South Korea is expected to reach a market size of US$ 6.5 million, expanding at a CAGR of 6.0% during the forecast period. South Korea is well-known for its technology breakthroughs and healthcare innovation. The country's strong emphasis on research and development, along with a favorable regulatory framework, leads to the growth of the lung cancer PCR panel market by allowing the development and commercialization of improved diagnostic technologies.
Principal Consultant
The Adenocarcinoma dominated the lung cancer PCR panel market industry with a market share of 55.0% in 2022. PCR panels play a significant role in the treatment of adenocarcinoma, which is the most common type of lung cancer. These panels help identify specific genetic mutations or alteration in tumor samples, allowing for personalized treatment strategies and improved patient outcomes. Moreover, the targeted therapies of the PCR panels have shown improved efficacy and better outcome compared to traditional chemotherapy in patients with the specific alterations. These therapies are gaining traction in lung cancer treatment as a result, the market is on the rise.
The dermatology clinics is dominating the lung cancer PCR panel market with the market share of 42.0% in 2022. Patients commonly visit specialty hospitals for rapid and efficient care, as the need for specialist treatments grows, fueling the segment's growth. Furthermore, due to the global increase in squamous cell carcinoma (SCC) and large cell carcinoma the more people are seeking treatment and care at hospitals.
The lung cancer PCR panel sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products
Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.
Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks. Or strategic alliances in various countries to strengthen their market position.
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Lung Cancer PCR Panel Market:
The market is valued at US$ 513.9 million in 2023.
The Lung Cancer PCR Panel Market CAGR for 2033 is 8%.
The forecast market value of the market for 2033 is US$ 1.1 billion.
The latest trend in the Lung Cancer PCR Panel Market is multi-gene panels & NGS enhance mutation detection in lung cancer, while liquid biopsy & companion diagnostics refine treatment selection.
F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, AstraZeneca plc are key market players.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Recent Product Approvals/Launches 4.3. Regulatory Landscape 4.4. PESTEL Analysis 4.5. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Medical Device Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Growing Awareness about Cancer Diseases 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for Minimally Invasive Procedures 5.2.5. Technological Advancement in the Devices 5.2.6. Increasing Prevalence of Lung Cancer 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2015 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2015 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Application 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 9.3.1. Adenocarcinoma 9.3.2. Squamous Cell Carcinoma (SCC) 9.3.3. Large cell carcinoma 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 10.3.1. Hospitals 10.3.2. Cancer Research Institutes 10.3.3. Specialty Clinics 10.3.4. Research & Educational Institutes 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2015 to 2022 11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. USA 12.3.1.2. Canada 12.3.2. By Application 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Application 12.4.3. By End User 12.5. Country Level Analysis & Forecast 12.5.1. USA Market Analysis 12.5.1.1. Introduction 12.5.1.2. Market Analysis and Forecast by Market Taxonomy 12.5.1.2.1. By Application 12.5.1.2.2. By End User 12.5.2. Canada Market Analysis 12.5.2.1. Introduction 12.5.2.2. Market Analysis and Forecast by Market Taxonomy 12.5.2.2.1. By Application 12.5.2.2.2. By End User 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 13. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Application 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Application 13.4.3. By End User 13.5. Country Level Analysis & Forecast 13.5.1. Brazil Market Analysis 13.5.1.1. Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Application 13.5.1.2.2. By End User 13.5.2. Mexico Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Application 13.5.2.2.2. By End User 13.5.3. Argentina Market Analysis 13.5.3.1. Introduction 13.5.3.2. Market Analysis and Forecast by Market Taxonomy 13.5.3.2.1. By Application 13.5.3.2.2. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. France 14.3.1.3. Italy 14.3.1.4. UK 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. BENELUX 14.3.1.8. Rest of Europe 14.3.2. By Application 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Application 14.4.3. By End User 14.5. Country Level Analysis & Forecast 14.5.1. Germany Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Application 14.5.1.2.2. By End User 14.5.2. France Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Application 14.5.2.2.2. By End User 14.5.3. Italy Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Application 14.5.3.2.2. By End User 14.5.4. UK Market Analysis 14.5.4.1. Introduction 14.5.4.2. Market Analysis and Forecast by Market Taxonomy 14.5.4.2.1. By Application 14.5.4.2.2. By End User 14.5.5. Spain Market Analysis 14.5.5.1. Introduction 14.5.5.2. Market Analysis and Forecast by Market Taxonomy 14.5.5.2.1. By Application 14.5.5.2.2. By End User 14.5.6. Russia Market Analysis 14.5.6.1. Introduction 14.5.6.2. Market Analysis and Forecast by Market Taxonomy 14.5.6.2.1. By Application 14.5.6.2.2. By End User 14.5.7. BENELUX Market Analysis 14.5.7.1. Introduction 14.5.7.2. Market Analysis and Forecast by Market Taxonomy 14.5.7.2.1. By Application 14.5.7.2.2. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Application 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Application 15.4.3. By End User 15.5. Country Level Analysis & Forecast 15.5.1. India Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Application 15.5.1.2.2. By End User 15.5.2. Thailand Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Application 15.5.2.2.2. By End User 15.5.3. Indonesia Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Application 15.5.3.2.2. By End User 15.5.4. Malaysia Market Analysis 15.5.4.1. Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Application 15.5.4.2.2. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Application 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Application 16.4.3. By End User 16.5. Country Level Analysis & Forecast 16.5.1. China Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Application 16.5.1.2.2. By End User 16.5.2. Japan Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Application 16.5.2.2.2. By End User 16.5.3. South Korea Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Application 16.5.3.2.2. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Application 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Application 17.4.3. By End User 17.5. Country Level Analysis & Forecast 17.5.1. Australia Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Application 17.5.1.2.2. By End User 17.5.2. New Zealand Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Application 17.5.2.2.2. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Market Analysis 2015 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. Northern Africa 18.3.1.4. South Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Application 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Application 18.4.3. By End User 18.5. Country Level Analysis & Forecast 18.5.1. GCC Countries Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Application 18.5.1.2.2. By End User 18.5.2. Türkiye Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Application 18.5.2.2.2. By End User 18.5.3. Northern Africa Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Application 18.5.3.2.2. By End User 18.5.4. South Africa Market Analysis 18.5.4.1. Introduction 18.5.4.2. Market Analysis and Forecast by Market Taxonomy 18.5.4.2.1. By Application 18.5.4.2.2. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Market Presence Analysis 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Amoy Diagnostics Co., Ltd. 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Key Financials 20.3.1.4. Sales Footprint 20.3.1.5. SWOT Analysis 20.3.1.6. Strategy Overview 20.3.1.6.1. Marketing Strategy 20.3.1.6.2. Product Strategy 20.3.1.6.3. Channel Strategy 20.3.2. ATRiDA B.V. 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Key Financials 20.3.2.4. Sales Footprint 20.3.2.5. SWOT Analysis 20.3.2.6. Strategy Overview 20.3.2.6.1. Marketing Strategy 20.3.2.6.2. Product Strategy 20.3.2.6.3. Channel Strategy 20.3.3. Diagnóstica Longwood 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Key Financials 20.3.3.4. Sales Footprint 20.3.3.5. SWOT Analysis 20.3.3.6. Strategy Overview 20.3.3.6.1. Marketing Strategy 20.3.3.6.2. Product Strategy 20.3.3.6.3. Channel Strategy 20.3.4. Paragon Genomics, Inc. 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Key Financials 20.3.4.4. Sales Footprint 20.3.4.5. SWOT Analysis 20.3.4.6. Strategy Overview 20.3.4.6.1. Marketing Strategy 20.3.4.6.2. Product Strategy 20.3.4.6.3. Channel Strategy 20.3.5. EntroGen’s 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Key Financials 20.3.5.4. Sales Footprint 20.3.5.5. SWOT Analysis 20.3.5.6. Strategy Overview 20.3.5.6.1. Marketing Strategy 20.3.5.6.2. Product Strategy 20.3.5.6.3. Channel Strategy 20.3.6. Jiangsu Mole Bioscience Co., Ltd. 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Key Financials 20.3.6.4. Sales Footprint 20.3.6.5. SWOT Analysis 20.3.6.6. Strategy Overview 20.3.6.6.1. Marketing Strategy 20.3.6.6.2. Product Strategy 20.3.6.6.3. Channel Strategy 20.3.7. Lepu Medical Technology (Beijing) Co.,Ltd. 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Key Financials 20.3.7.4. Sales Footprint 20.3.7.5. SWOT Analysis 20.3.7.6. Strategy Overview 20.3.7.6.1. Marketing Strategy 20.3.7.6.2. Product Strategy 20.3.7.6.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Lung Cancer PCR Panel Market
